Cellular apoptosis · target hub

TP53

TP53 (TP53)

TP53 is a BCL-2 family on the Apoptosis signaling pathway axis. Validate with UniProt and literature. Indexed under "p53 & DNA-damage axis" for antibodies and assay guidance.

Research notes

  • Combine with module neighbors to test non-redundant roles of TP53.
  • Pair phospho/phenotypic readouts with stimulation and inhibitor controls.
  • Validate antibody clone and compartment; include KD/KO controls.

On the pathway hub (sections)

Genetic lesions & expression context (quick reference)

Type / exampleDomain / context (brief)
Loss-of-functionLoss/truncation
CN lossCopy loss
Rare missenseRequire functional validation

Naming and prevalence vary—annotate clinically with authoritative databases.

Assay readouts for TP53

  • BAX/BAK activation and MOMP.
  • BH3-only induction (BIM/PUMA/BID).
  • BCL-2 inhibitor sensitivity.
  • Pair with caspase cleavage.

TP53 experimental notes

Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.

[1] Cell lines commonly used for TP53 studies (examples)

  • Tool lines: HeLa, Jurkat, MCF-7, HCT116—screen by TP53 expression (CCLE/DepMap).
  • Combine with neighbors (CDKN1A, BBC3, PMAIP1, GADD45A) via KD/pharmacology.
  • Overexpression/rescue in HEK293T supports mechanism and IP.
  • Isogenic/CRISPR models separate dependency from bypass.

[2] Cell samples for TP53 Western blot

  • Whole-cell lysates; phosphatase inhibitors for phospho blots.
  • Optimize stimulation time courses per ligand/stress.
  • Controls: KD/KO or inhibitors.
  • BCA normalization; subcellular fractionation when needed.

[3] Tissue samples for TP53 Western blot

  • Matched tumor/adjacent frozen tissues.
  • Mouse models—mind species cross-reactivity.
  • Primary cells/PDCs when approved.
  • FFPE needs specialized extraction; frozen preferred for phospho.

[4] Cell samples for TP53 immunoprecipitation

  • Tagged overexpression: HEK293T FLAG/HA-TP53.
  • Endogenous IP: high-expression lines.
  • Stimulation enriches interactions.
  • Controls: isotype IgG, empty vector, KO.

Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.

Bypass & related pathways

Models & genetics note

Overexpression vs endogenous TP53 can differ in dosage, splicing, and compartmentation.

Quick search presets

TP53-related antibodies (keyword-biased)

Adds TP53 keyword bias atop the 凋亡信号通路 antibody pool—if sparse, use presets above or global search.

FAQ

This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.

Last reviewed: 2026-05-18

Related on this site

See the cellular apoptosis hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.